102 related articles for article (PubMed ID: 146545)
1. [The occurrence of glucuroconjugated metabolites of safrole in the urine of treated rats].
Levi P; Janiaud P; Delaforge M; Morizot JP; Maume BF; Padieu P
C R Seances Soc Biol Fil; 1977; 171(5):1034-40. PubMed ID: 146545
[TBL] [Abstract][Full Text] [Related]
2. Determination of n-hexane metabolites by liquid chromatography/mass spectrometry. 2. Glucuronide-conjugated metabolites in untreated urine samples by electrospray ionization.
Manini P; Andreoli R; Mutti A; Bergamaschi E; Niessen WM
Rapid Commun Mass Spectrom; 1998; 12(21):1615-24. PubMed ID: 9807835
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the biliary and urinary glutathione and N-acetylcysteine metabolites of the hepatic carcinogen 1'-hydroxysafrole and its 1'-oxo metabolite in rats and mice.
Fennell TR; Miller JA; Miller EC
Cancer Res; 1984 Aug; 44(8):3231-40. PubMed ID: 6744260
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of isosafrole and dihydrosafrole in the rat.
Klungsøyr J; Scheline RR
Biomed Mass Spectrom; 1982 Aug; 9(8):323-9. PubMed ID: 7126764
[TBL] [Abstract][Full Text] [Related]
5. The metabolism of safrole and 2',3'-epoxysafrole in the rat and guinea pig.
Stillwell W; Carman JK; Bell L; Horning MG
Drug Metab Dispos; 1974; 2(6):489-98. PubMed ID: 4155673
[No Abstract] [Full Text] [Related]
6. The metabolic activation of the carcinogen 1'-hydroxysafrole in vivo and in vitro and the electrophilic reactivities of possible ultimate carcinogens.
Wislocki PG; Borchert P; Miller JA; Miller EC
Cancer Res; 1976 May; 36(5):1686-95. PubMed ID: 5188
[TBL] [Abstract][Full Text] [Related]
7. [Metabolic activation by adrenal tissue in rats of a liver carcinogen: safrole].
Doumas J; Maume BF
C R Seances Soc Biol Fil; 1977; 171(1):108-14. PubMed ID: 143305
[TBL] [Abstract][Full Text] [Related]
8. [A comparative study in cultured rat liver cells of the metabolism of different analogues and metabolites of a natural hepatocarcinogen: safrol].
Janiaud P; Delaforge M; Levi P; Maume BF; Padieu P
C R Seances Soc Biol Fil; 1976; 170(5):1035-41. PubMed ID: 139975
[TBL] [Abstract][Full Text] [Related]
9. Characterization of glucuronide metabolites of carbamazepine in human urine by gas chromatography and mass spectrometry.
Lynn RK; Smith RG; Thompson RM; Deinzer ML; Griffin D; Gerber N
Drug Metab Dispos; 1978; 6(4):494-501. PubMed ID: 28932
[TBL] [Abstract][Full Text] [Related]
10. Carcinogenic and mutagenic activities of safrole, 1'-hydroxysafrole, and some known or possible metabolites.
Wislocki PG; Miller EC; Miller JA; McCoy EC; Rosenkranz HS
Cancer Res; 1977 Jun; 37(6):1883-91. PubMed ID: 192464
[No Abstract] [Full Text] [Related]
11. N2 atom of guanine and N6 atom of adenine residues as sites for covalent binding of metabolically activated 1'-hydroxysafrole to mouse liver DNA in vivo.
Phillips DH; Miller JA; Miller EC; Adams B
Cancer Res; 1981 Jul; 41(7):2664-71. PubMed ID: 7248936
[TBL] [Abstract][Full Text] [Related]
12. Strong evidence from studies with brachymorphic mice and pentachlorophenol that 1'-sulfoöxysafrole is the major ultimate electrophilic and carcinogenic metabolite of 1'-hydroxysafrole in mouse liver.
Boberg EW; Miller EC; Miller JA; Poland A; Liem A
Cancer Res; 1983 Nov; 43(11):5163-73. PubMed ID: 6577945
[TBL] [Abstract][Full Text] [Related]
13. Absorption, metabolism and excretion of safrole in the rat and man.
Benedetti MS; Malnoë A; Broillet AL
Toxicology; 1977 Feb; 7(1):69-83. PubMed ID: 14422
[TBL] [Abstract][Full Text] [Related]
14. Physiologically based biokinetic (PBBK) model for safrole bioactivation and detoxification in rats.
Martati E; Boersma MG; Spenkelink A; Khadka DB; Punt A; Vervoort J; van Bladeren PJ; Rietjens IM
Chem Res Toxicol; 2011 Jun; 24(6):818-34. PubMed ID: 21446753
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of safrole in the rat.
Klungsøyr J; Scheline RR
Acta Pharmacol Toxicol (Copenh); 1983 Mar; 52(3):211-6. PubMed ID: 6846029
[TBL] [Abstract][Full Text] [Related]
16. Proceedings: Properties of the safrole metabolite-cytochrome P-450 complex.
Elcombe CR; Bridges JW; Netter KJ
Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R72. PubMed ID: 1143487
[No Abstract] [Full Text] [Related]
17. Metabolism of the proximate carcinogen 1'-hydroxysafrole and the isomer 3'-hydroxyisosafrole.
Peele JD; Oswald EO
Bull Environ Contam Toxicol; 1978 Apr; 19(4):396-402. PubMed ID: 656641
[No Abstract] [Full Text] [Related]
18. The metabolic sulfonation and side-chain oxidation of 3'-hydroxyisosafrole in the mouse and its inactivity as a hepatocarcinogen relative to 1'-hydroxysafrole.
Boberg EW; Miller EC; Miller JA
Chem Biol Interact; 1986; 59(1):73-97. PubMed ID: 3757147
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of 3-(hydroxymethyl)-8-methoxychromone in the rat. II. Classification and identification of urinary drug metabolites.
Crew MC; Melgar MD; George S; Greenough RC; Szpiech JM; Di Carlo J
Xenobiotica; 1976 Feb; 6(2):89-100. PubMed ID: 1274377
[TBL] [Abstract][Full Text] [Related]
20. The metabolism of the naturally occurring hepatocarcinogen safrole to 1'-hydroxysafrole and the electrophilic reactivity of 1'-acetoxysafrole.
Borchert P; Wislocki PG; Miller JA; Miller EC
Cancer Res; 1973 Mar; 33(3):575-89. PubMed ID: 4689905
[No Abstract] [Full Text] [Related]
[Next] [New Search]
